Abbott
Healthcare that works
Abbott Park, Illinois, U.S.
Abbott is a market leader in RPM with device portfolio.
How We Help
Core Technology
Continuous Glucose Monitoring (CGM), Advanced Medical Devices, Diagnostic Platforms, Molecular Diagnostics, Pharmaceutical Formulations, Biowearables
Key Differentiators
Diversified Portfolio, Innovation and R&D (invested $2.4 billion in R&D in 2021), Global Presence (operates in over 160 countries), Strong Brand Equity (e.g., FreeStyle Libre, Similac, Ensure, Glucerna), Operational Scale and Manufacturing Footprint (across approximately 90 sites), Patient-Centric Solutions, Strategic Acquisitions and Divestitures, Diagnostic Capabilities
Clinical Focus
Diabetes care, structural heart conditions, cardiac rhythm management, heart failure monitoring, vascular health, neuromodulation, infectious disease diagnostics, nutritional support, gastroenterology, women's health, cardiometabolic disorders, pain management, central nervous system disorders, respiratory health, oncology, blood disorders, traumatic brain injury.
Target Customers
Patients, healthcare providers (physicians, hospitals, clinics), consumers, governments, and emerging markets.
Product Stage
Mature
Company Info
- Business Model
- Diversified healthcare model with four main segments: Medical Devices (diabetes care, structural heart, cardiac rhythm management, vascular, neuromodulation), Diagnostics (core lab, molecular, point-of-care, rapid diagnostics, transfusion medicine), Nutritional Products (pediatric, adult, specialty nutrition), and Established Pharmaceuticals (off-patent branded generics primarily in emerging markets).
- Founded
- 1888
- Website
- www.abbott.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
FreeStyle Libre published in NEJM with HbA1c reductions. AVEIR dual-chamber pacemaker: 98% implant success. Tendyne TMVR FDA approved May 2025. Comprehensive peer-reviewed trials across all therapeutic areas.
MedStartr Index Score
?What do you think of Abbott?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.